Day: July 29, 2025

Annual recurring revenues grew 19% year-over-yearSaaS ARR as a percentage of total ARR was approximately 69%Year-to-date cash from operations generated $89.3 million vs. $68.4 million last yearYear-to-date free cash flow generated $82.7 million vs. $67.3 million last year MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, today announced financial results for the second quarter ended June 30, 2025. Yaki Faitelson, Varonis CEO, said, “We are excited by the many tailwinds we are seeing in our business. The simplicity and automated outcomes of our SaaS platform and MDDR, the adoption of AI and the growing awareness for data-centric cloud and SaaS security are continuing to drive momentum in our business, and we look forward to executing on this massive and growing market...

– Signed 190,000 square feet of comparable leases at 22% growth in cash rent spread –– Reaffirmed 2025 Outlook – WINTER PARK, Fla., July 29, 2025 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”), an owner and operator of retail-based properties located primarily in higher-growth markets, today announced its operating and financial results for the quarter ended June 30, 2025. Second Quarter 2025 HighlightsNet Loss attributable to common stockholders of $(0.77) per diluted share. Core Funds from Operations (“FFO”) attributable to common stockholders, of $0.45 per diluted share. Adjusted Funds from Operations (“AFFO”) attributable to common stockholders of $0.47 per diluted share. Signed 190,027 square feet of comparable leases at a positive cash rent spread of 21.6%. Current signed-not-open pipeline...

– Appointed Dr. Roger Sidhu as Chief Medical Officer – – Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) – – Announced positive data from investigator-initiated trial of onvansertib in combination with paclitaxel in mTNBC at ASCO 2025 – – Cash and investments of $71.0 million as of June 30, 2025, projected runway into Q1 2027 – – Company to hold a conference call today at 4:30 p.m. ET/1:30 p.m. PT to share updated clinical data from the CRDF-004 trial – SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range...

MONACO, July 29, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three and six-month periods ended June 30, 2025. The Board of Directors (the “Board”) of the Company also declared a cash dividend of $0.05 per share of outstanding common stock.Financial highlights            In million U.S. Dollars except per share data Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Six Months 2025 Six Months 2024Net revenues 65.7 64.3 71.5 75.9 78.5 130.1 160.2Net income 1.7 7.2 19.4 25.1 27.6 8.9 52.9Adjusted Net income1 3.0 7.8 18.1 19.0 20.3 10.7 44.5EBITDA2 24.2 28.8 41.9 47.4 49.2 53.1 97.1Adjusted EBITDA2 25.5 29.4 40.7 41.3 41.8 54.9 88.7Earnings per share...

OKLAHOMA CITY, July 29, 2025 (GLOBE NEWSWIRE) — Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy” or the “Company”) today reported second quarter 2025 financial and operating results.Net cash provided by operating activities of $1,322 million Net income of $968 million, or $4.02 per fully diluted share; adjusted net income(1) of $265 million, or $1.10 per share Adjusted EBITDAX(1) of $1,176 million Produced ~7.20 Bcfe/d net (92% natural gas) Delivered the highest average drilled footage per day in all three business units Reduced full year 2025 drilling and completion capital expenditures guidance by ~$100 million to achieve ~$2.9 billion total capital expenditures Increased annual synergy outlook to $600 million by year end 2026 Announced ~$425 million of incremental free cash flow in 2025, primarily driven by improved...

IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2025 and raised its full year guidance for the year ending December 31, 2025. Second Quarter 2025 Financial Results & Key MetricsNet sales of $23.2 million, up 54% compared to $15.0 million in the second quarter of 2024.Durable Medical Equipment (DME) channel net sales of $18.6 million, up 31% compared to $14.3 million in the second quarter of 2024. Pharmacy Benefit Plan (PBP) channel net sales of $4.6 million, up 498% compared to $0.8 million in the second quarter of 2024.Gross margin of 53.8%, up 7 basis points compared to 53.7% in the second quarter of 2024. Installed customer base (calculated...

2025 Second Quarter Revenue of $514.5 Million, up 14.7% year-over-year Q2 Diluted EPS (GAAP) of $0.40, up 43.9% from $0.28 in Q2 of 2024 Q2 Adjusted Diluted EPS (Non-GAAP) (1) of $0.49, up 20.3% from $0.40 in Q2 of 2024 NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today announced its financial results for the quarter ended June 30, 2025. Chairman and Chief Executive Officer Rohit Kapoor said, “I am pleased to report another strong quarter as we delivered revenue growth of 15% and increased our adjusted diluted EPS by 20%. Our sustained double-digit growth demonstrates the strength of our competitive position as a global data and AI company. EXL’s recognized leadership in embedding AI in the workflow is resonating strongly with our clients and fueling our growth.” Chief...

EL SEGUNDO, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Big 5 Sporting Goods Corporation (Nasdaq: BGFV) (the “Company,” “we,” “our,” “us,” “Big 5”), a leading sporting goods retailer, today reported financial results for the fiscal 2025 second quarter ended June 29, 2025. Net sales were $184.9 million compared to net sales of $199.8 million for the second quarter of fiscal 2024. Same store sales decreased 6.1% for the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024. Gross profit for the fiscal 2025 second quarter was $52.2 million, compared to $58.7 million in the second quarter of the prior year. The Company’s gross profit margin was 28.2% in the fiscal 2025 second quarter versus 29.4% in the second quarter of the prior year. The decrease in gross profit margin compared with the prior year primarily reflected...

THEON Belgium_Brussels OfficeTHEON Belgium_Brussels OfficeTHEON Production Facility at Zaventem, BelgiumTHEON Production Facility at Zaventem, BelgiumPRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)THEON announces formation of Theon Belgium subsidiary and establishment of new facilities in Belgium. Minority stake acquisition in Andres Industries to expand European presence and enhance digital/thermal capabilities.29 July 2025 – Theon International Plc (THEON) is pleased to announce the formation of its 100% owned subsidiary, Theon Belgium. This strategic move follows the growing global traction of its A.R.M.E.D. product series and the high growth prospects for this line of products. Via its new wholly owned Theon Belgium, THEON is establishing a new production facility at Zaventem as well as a liaison...